Please assess the completion status of the following clinical trial:

Trial Title: Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients older than 18 years with symptomatic hemorrhoidal disease grade II and III (Goligher's classification)~* Refractory to conservative therapy (dietary modification, intestinal transit modifiers, topical and phlebotonic medications) for a period of not less than 4 weeks~Exclusion Criteria:~* Cirrhosis~* Pregnant or breast-feeding women~* Known allergy to polidocanol~* Another perianal disease that can cause symptoms similar to hemorrhoidal disease~* Colorectal malignancy~* Concomitant presence of external hemorrhoidal disease and/or hemorrhoidal thrombosis - - Office or surgical treatment for hemorrhoids within 6 months prior to inclusion~* Antiplatelet or hypocoagulant medication~* Hematological disorders~* Immunosuppressive states~* Inflammatory bowel disease~* Patients unable to have general or spinal anesthetic

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Polidocanol foam sclerotherapy (Type: ACTIVE_COMPARATOR): Patients submitted to polidocanol foam sclerotherapy
- Doppler-guided hemorrhoidal artery ligation (Type: ACTIVE_COMPARATOR): Patients submitted to doppler-guided hemorrhoidal artery ligation

Based on this trial design, predict the completion outcome and termination type (if applicable).